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“It was the best of times, it was the worst of times” quoting Charles Dickens, I feel living in an era very similar to those 
times, with an ever widening gap between the different economical classes in our society. With the relative 
improvement in Health services across Pakistan may over the last 70 years and the absolute disastrous growth of 2.4% 
in population within the last decade, there is still a lot of disparity between the health care demand and supply for 
common man.1
The burden of meeting the health problems primarily lies on the population itself. The picture gets grimmer with the 
conditions of economy, law and order situations, war of terror and geopolitical conditions of Pakistan.
State of the art institutions have sprung up in almost all major cities of Pakistan. All patients ranging from minor 
ailments to illnesses with dire consequences try to reach these set ups; the non-availability of basic health services 
being a strong reason for that. The uncertainty of the day to day life in our country has a heavy toll on this aspect as 
well, as the public sector institutes are unable to cater for the needs of our ever-growing population. The quality of 
services offered by the private hospitals in return of a heavy fee is not always optimal.
Medicines available in the market are of varying quality, original and fake both available in the market with identical 
packing and prices. Only using them would make one know if they are effective or not. Besides that every now and 
then essential medications are withdrawn from the market at the spur of the moment and patients are left desperate 
to find alternatives at a short notice
A similar scenario has been witnessed from time to time in the Pediatric neurology clinical services, where essential 
Anti-epileptic medications which form the backbone of Epilepsy treatment in Childhood Epilepsies are withdrawn from 
the market every now and then. Pediatric Epilepsies have a good outcome by 65-70%, leaving a 30-35% to carry it 
into adulthood.2-6 A false deficit is created and then medicines are reintroduced in the market with raised prices. This 
is a vicious cycle and in the past five years at least 4-5 such medicines have been removed from market causing 
immense emotional trauma for those who are taking these medicines in maintenance and resulted in break through 
seizure crises with disastrous outcomes.
A well-known brand of Valproate and Oxcarbamazepine, which are excellent broad spectrum anti-epileptic drugs written 
widely by pediatricians, has recently come in a fresh packing. A number of parents have reported using different 
colored syrup in the same packing which are totally different from the original colors. Incidence of breakthrough 
seizures have also increased with the different colors of the syrup in spite of increasing the doses. 
Another interesting fact about all this is that the pediatric formulations disappear quicker than adult form of 
medications. Parents do rationing and when such an artificial deficit is created at that time four fold high price has also 
been paid to avoid total deficiency. Treatment of epilepsy in children is by tailoring medicines to the requirement of 
individuals according to age, gender, weight, number of medicines being administered and other existing co morbid 
conditions.
Summarizing it, the drug has effects on the body and body has effects on the drug. Using alternative medications when 
such false crisis are developed, is the only choice left for the neurologists and pediatricians who deal with the burden 
of epilepsy in children in a resource poor country like Pakistan. So the painstaking process of tailoring restarts with the 
disappearance of each anti-epileptic medicine, which takes quite some time for the adjustments to quantify.
Such happenings as it appears will be the norm of our practices in the times to come. Can it be reduced by the higher 
control authorities by having specific price control codes which are implemented strictly? The uncertainty of the 
situation hangs ominously without any way out or hope of getting out of it.
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